ADVISORS SERIES TRUST
NSAR-B, EX-27.15, 2000-08-14
Previous: ADVISORS SERIES TRUST, NSAR-B, EX-27.13, 2000-08-14
Next: EPIX MEDICAL INC, 10-Q, 2000-08-14



<TABLE> <S> <C>

<ARTICLE> 6
<CIK> 1027596
<NAME> ADVISORS SERIES TRUST
<SERIES>
   <NUMBER> 15
   <NAME> UNITY FUND
<MULTIPLIER> 1
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          MAY-31-2000
<PERIOD-START>                             JUN-01-1999
<PERIOD-END>                               MAY-31-2000
<EXCHANGE-RATE>                                      1
<INVESTMENTS-AT-COST>                        1,838,801
<INVESTMENTS-AT-VALUE>                       1,860,753
<RECEIVABLES>                                  100,154
<ASSETS-OTHER>                                  31,249
<OTHER-ITEMS-ASSETS>                                 0
<TOTAL-ASSETS>                               1,992,240
<PAYABLE-FOR-SECURITIES>                             0
<SENIOR-LONG-TERM-DEBT>                              0
<OTHER-ITEMS-LIABILITIES>                      111,722
<TOTAL-LIABILITIES>                            111,722
<SENIOR-EQUITY>                                      0
<PAID-IN-CAPITAL-COMMON>                     1,910,116
<SHARES-COMMON-STOCK>                          192,227
<SHARES-COMMON-PRIOR>                          354,913
<ACCUMULATED-NII-CURRENT>                     (10,031)
<OVERDISTRIBUTION-NII>                               0
<ACCUMULATED-NET-GAINS>                       (41,517)
<OVERDISTRIBUTION-GAINS>                             0
<ACCUM-APPREC-OR-DEPREC>                        21,950
<NET-ASSETS>                                 1,880,518
<DIVIDEND-INCOME>                               76,799
<INTEREST-INCOME>                                1,726
<OTHER-INCOME>                                       0
<EXPENSES-NET>                                  65,044
<NET-INVESTMENT-INCOME>                         13,481
<REALIZED-GAINS-CURRENT>                      (41,517)
<APPREC-INCREASE-CURRENT>                    (352,649)
<NET-CHANGE-FROM-OPS>                        (380,685)
<EQUALIZATION>                                       0
<DISTRIBUTIONS-OF-INCOME>                       19,723
<DISTRIBUTIONS-OF-GAINS>                       115,019
<DISTRIBUTIONS-OTHER>                                0
<NUMBER-OF-SHARES-SOLD>                        387,677
<NUMBER-OF-SHARES-REDEEMED>                    563,262
<SHARES-REINVESTED>                             12,899
<NET-CHANGE-IN-ASSETS>                     (2,175,167)
<ACCUMULATED-NII-PRIOR>                         13,267
<ACCUMULATED-GAINS-PRIOR>                       97,964
<OVERDISTRIB-NII-PRIOR>                              0
<OVERDIST-NET-GAINS-PRIOR>                           0
<GROSS-ADVISORY-FEES>                           26,342
<INTEREST-EXPENSE>                                   0
<GROSS-EXPENSE>                                165,648
<AVERAGE-NET-ASSETS>                         3,095,466
<PER-SHARE-NAV-BEGIN>                            11.43
<PER-SHARE-NII>                                 (0.18)
<PER-SHARE-GAIN-APPREC>                         (1.00)
<PER-SHARE-DIVIDEND>                              0.07
<PER-SHARE-DISTRIBUTIONS>                         0.40
<RETURNS-OF-CAPITAL>                                 0
<PER-SHARE-NAV-END>                               9.78
<EXPENSE-RATIO>                                   2.10


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission